Skip to main content

Table 2 Comparison of the genotype frequencies between control subjects and HIV/AIDS patients

From: PXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients

SNP

Genotype

Location/functional effect

Healthy subjects

HIV/AIDS patients

Global p-value

n (freq)

n (freq)

NR1I2 rs3732356T>G

T/T

Intron 3

95 (0.605)

162 (0.549)

0.031

T/G

 

50 (0.318)

123 (0.417)

 

G/G

 

12 (0.076)

10 (0.034)

 

NR1I2 rs2472677C>T

C/C

Intron 1, Disrupts HNF3B TFB site

57 (0.368)

97 (0.365)

0.917

C/T

75 (0.484)

133 (0.500)

 

T/T

23 (0.148)

36 (0.135)

 

NR1I2 rs6785049G>A

G/G

Intron 5

128 (0.853)

264 (0.950)

0.002

G/A

21 (0.140)

14 (0.050)

 

A/A

1 (0.007)

0 (0.000)

 

NR1I3 rs2307424C>T

C/C

Exon 5, Pro180Pro

138 (0.879)

270 (0.915)

0.216

C/T

19 (0.121)

25 (0.085)

 

NR1I3 rs3003596T>C

T/T

Intron 3

51 (0.325)

100 (0.341)

0.659

T/C

72 (0.459)

140 (0.478)

 

C/C

34 (0.217)

53 (0.181)

 

NR1I3 rs2502815C>T

C/C

Intron 3

88 (0.564)

180 (0.610)

0.173

C/T

53 (0.340)

100 (0.339)

 

T/T

15 (0.096)

15 (0.051)

Â